Good Publication Practice (GPP) guidelines for company-sponsored biomedical research from the point of view of the diverse authors involved in its publication.

The Good Publication Practice (GPP) guidelines for company-sponsored biomedical research were updated in 2022 and have generated correspondence and commentary. The guidelines were developed by the International Society for Medical Publication Professionals (ISMPP) and cover various topics such as publication types, ethical principles, authorship, and publication process. The updated guidelines reflect the need for responsible publication planning and management in all stages of clinical development and all types of biomedical research. The guidelines are relevant to academia, medical communications agencies, publishers, and editors, and aim to promote ethics, transparency, and best practices in biomedical research publications. Future iterations of the guidelines may address topics such as artificial intelligence and the role of patients. [Extracted from the article]